1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- C3 glomerulopathy — understanding a rare complement-driven renal disease
- 2017
- Vitronectin Binds to a Specific Stretch within the Head Region of Yersinia Adhesin A and Thereby Modulates Yersinia enterocolitica Host Interaction
- 2016
- Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif.
- The complement inhibitor factor H generates an anti-inflammatory and tolerogenic state in monocyte-derived dendritic cells
- 2015
- Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack.
- Moraxella catarrhalis binds plasminogen to evade host innate immunity.
- 2014
- Identification of a Haemophilus influenzae Factor H-Binding Lipoprotein Involved in Serum Resistance.
- Candida albicans Uses the Surface Protein Gpm1 to Attach to Human Endothelial Cells and to Keratinocytes via the Adhesive Protein Vitronectin.
- 2013
- Human complement control and complement evasion by pathogenic microbes - Tipping the balance
- CspA from Borrelia burgdorferi Inhibits the Terminal Complement Pathway